Your browser doesn't support javascript.
loading
A randomized, double-blind, placebo-controlled trial of aldafermin in patients with NASH and compensated cirrhosis.
Rinella, Mary E; Lieu, Hsiao D; Kowdley, Kris V; Goodman, Zachary D; Alkhouri, Naim; Lawitz, Eric; Ratziu, Vlad; Abdelmalek, Manal F; Wong, Vincent Wai-Sun; Younes, Ziad H; Sheikh, Aasim M; Brannan, Donald; Freilich, Bradley; Membreno, Fernando; Sinclair, Marie; Melchor-Khan, Liza; Sanyal, Arun J; Ling, Lei; Harrison, Stephen A.
Afiliação
  • Rinella ME; University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA.
  • Lieu HD; NGM Biopharmaceuticals, South San Francisco, California, USA.
  • Kowdley KV; Washington State University, Spokane, Washington, USA.
  • Goodman ZD; Liver Institute Northwest, Seattle, Washington, USA.
  • Alkhouri N; Inova Health System, Falls Church, Virginia, USA.
  • Lawitz E; Arizona Liver Health, Tucson, Arizona, USA.
  • Ratziu V; Texas Liver Institute, University of Texas Health San Antonio, San Antonio, Texas, USA.
  • Abdelmalek MF; Sorbonne Université, ICAN Institute for Cardiometabolism and Nutrition, Assistance Publique Hôpitaux de Paris, INSERM UMRS 1138 CRC.
  • Wong VW; Mayo Clinic, Rochester, Minnesota, USA.
  • Younes ZH; The Chinese University of Hong Kong, Hong Kong, China.
  • Sheikh AM; Gastro One, Germantown, Tennessee, USA.
  • Brannan D; GI Specialists of Georgia, Atlanta, Georgia, USA.
  • Freilich B; Gastrointestinal Associates, Flowood, Mississippi, USA.
  • Membreno F; Kansas City Research Institute, Kansas City, Missouri, USA.
  • Sinclair M; DHR Health Transplant Institute, McAllen, Texas, USA.
  • Melchor-Khan L; Austin Health, Heidleberg, Australia.
  • Sanyal AJ; NGM Biopharmaceuticals, South San Francisco, California, USA.
  • Ling L; Virginia Commonwealth University, Richmond, Virginia, USA.
  • Harrison SA; NGM Biopharmaceuticals, South San Francisco, California, USA.
Hepatology ; 79(3): 674-689, 2024 Mar 01.
Article em En | MEDLINE | ID: mdl-37732990

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fatores de Crescimento de Fibroblastos / Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Hepatology Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Fatores de Crescimento de Fibroblastos / Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Hepatology Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos